Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC.

[1]  S. Leptihn,et al.  Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii , 2019, Antimicrobial Agents and Chemotherapy.

[2]  Ruobing Wang,et al.  [Molecular epidemiology and resistance mechanisms of tigecycline-non-susceptible Acinetobacter baumannii]. , 2018, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[3]  A. Ardebili,et al.  AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant Acinetobacter baumannii clinical isolates , 2018, The Indian journal of medical research.

[4]  H. Cao,et al.  Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii , 2018, Infection and drug resistance.

[5]  Qingya Dou,et al.  [AdeABC efflux pump and resistance of Acinetobacter baumannii against carbapenem]. , 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[6]  W. Jeng,et al.  Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.

[7]  A. Ivens,et al.  The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner , 2016, mBio.

[8]  J. Karlowsky,et al.  Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent , 2016, Drugs.

[9]  M. Almuzara,et al.  Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates , 2015, Current Microbiology.

[10]  D. Landman,et al.  Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City , 2014, Antimicrobial Agents and Chemotherapy.

[11]  M. Bassetti,et al.  Eravacycline for the treatment of intra-abdominal infections , 2014, Expert opinion on investigational drugs.

[12]  Daniel N. Wilson,et al.  Tetracycline antibiotics and resistance mechanisms , 2014, Biological chemistry.

[13]  H. Giamarellou,et al.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.

[14]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[15]  Jeffrey E. Barrick,et al.  Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. , 2014, Methods in molecular biology.

[16]  T. Grossman,et al.  Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens , 2013, Antimicrobial Agents and Chemotherapy.

[17]  Ming-Chin Chan,et al.  A Truncated AdeS Kinase Protein Generated by ISAba1 Insertion Correlates with Tigecycline Resistance in Acinetobacter baumannii , 2012, PloS one.

[18]  Michael T Laub,et al.  Evolution of two-component signal transduction systems. , 2012, Annual review of microbiology.

[19]  Rui Wang,et al.  Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.

[20]  Daniel N. Wilson,et al.  Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic , 2012, Antimicrobial Agents and Chemotherapy.

[21]  N. Loman,et al.  Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. , 2011, The Journal of antimicrobial chemotherapy.

[22]  J. Quinn,et al.  AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[23]  Ronald N. Jones,et al.  The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). , 2010, The Journal of infection.

[24]  Diarmaid Hughes,et al.  Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.

[25]  V. Srinivasan,et al.  Role of AbeS, a Novel Efflux Pump of the SMR Family of Transporters, in Resistance to Antimicrobial Agents in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.

[26]  M. Falagas,et al.  Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. , 2008, The Lancet. Infectious diseases.

[27]  A. Antoniadou,et al.  Acinetobacter baumannii: a universal threat to public health? , 2008, International journal of antimicrobial agents.

[28]  P. Bradford,et al.  AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. , 2007, The Journal of antimicrobial chemotherapy.

[29]  D. Paterson,et al.  Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.

[30]  L. Friedman,et al.  Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus , 2006, Antimicrobial Agents and Chemotherapy.

[31]  L. Piddock.  Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.

[32]  P. Courvalin,et al.  Expression of the RND-Type Efflux Pump AdeABC in Acinetobacter baumannii Is Regulated by the AdeRS Two-Component System , 2004, Antimicrobial Agents and Chemotherapy.

[33]  Qing Yang,et al.  Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. , 2004, Journal of medical microbiology.

[34]  S. Magnet,et al.  Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.

[35]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[36]  I. Paulsen,et al.  Proton-dependent multidrug efflux systems , 1996, Microbiological reviews.